Strength of ICR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation

被引:0
|
作者
Tao, X
Constant, S
Jorritsma, P
Bottomly, K
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[2] Howard Hughes Med Inst, New Haven, CT 06510 USA
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Differentiation of naive CD4 T cells into cytokine-secreting effector Th1 and Th2 cells is influenced by several factors. We have previously reported that the affinity of antigen for TCR and antigen dose can influence the differentiation of Th1 and Th2 cells. Several in vitro and in vivo models have demonstrated a role for the costimulatory molecules, B7-1 (CD80) and B7-2 (CD86), in the generation of distinct effector T cell responses. To determine whether the strength of TCR signaling controls the involvement of CD28 costimulation in selective CD4 T cell differentiation, naive CD4 T cells bearing a transgenic TCR are primed by a weak or strong TCR signal (signal 1) in the presence or absence of B7 costimulatory molecules (signal 2). In this system, IL-4-producing Th2 cells are generated by priming with a weak but not a strong TCR signal. Th2 cell differentiation is dependent on CD28/B7 interactions in that disruption of CD28/B7 interactions inhibits the priming of Th2 cells and cross-linking CD28 with anti-CD28 antibody augments the priming of Th2 cells. In contrast, however, IL-4-producing Th2 cells cannot be generated by priming with a strong TCR signal even in the presence of strong costimulation or high doses of IL-2. Thus, our results suggest that naive CD4 T cells are receptive to CD28-dependent IL-4 production only if they receive a weak TCR signal.
引用
收藏
页码:5956 / 5963
页数:8
相关论文
共 50 条
  • [41] 卵巢早衰患者外周血CD4+、Th1/Th2细胞分布研究
    杨桂艳
    王一理
    曹缵
    孙李旭
    生殖医学杂志, 1998, (04) : 36 - 39
  • [42] Expression of Chemokine Receptors on Th1/Th2 CD4+ Lymphocytes in Patients with Multiple Sclerosis
    Andalib, Alireza
    Doulabi, Hassan
    Najafi, Mohamadreza
    Tazhibi, Mehdi
    Rezaie, Abbas
    IRANIAN JOURNAL OF IMMUNOLOGY, 2011, 8 (01) : 1 - 10
  • [43] Location of CD4+ T Cell Priming Regulates the Differentiation of Th1 and Th17 Cells and Their Contribution to Arthritis
    Rodeghero, Rachel
    Cao, Yanxia
    Olalekan, Susan A.
    Iwakua, Yoichiro
    Glant, Tibor T.
    Finnegan, Alison
    JOURNAL OF IMMUNOLOGY, 2013, 190 (11): : 5423 - 5435
  • [44] Primary γδ cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation
    Wen, L
    Barber, DF
    Pao, W
    Wong, FS
    Owen, MJ
    Hayday, A
    JOURNAL OF IMMUNOLOGY, 1998, 160 (04): : 1965 - 1974
  • [45] Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4+ T cells
    Abelardo Medina
    Aziz Ghahary
    Molecular and Cellular Biochemistry, 2011, 346 : 89 - 94
  • [46] The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells
    Lúdvíksson, BR
    Seegers, D
    Resnick, AS
    Strober, W
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (07) : 2101 - 2111
  • [47] Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells
    Bozza, M
    Bliss, JL
    Dorner, AJ
    Trepicchio, WL
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (01): : 21 - 30
  • [48] Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1/2 hybrid cells
    Burt, Philipp
    Peine, Michael
    Peine, Caroline
    Borek, Zuzanna
    Serve, Sebastian
    Flossdorf, Michael
    Hegazy, Ahmed N.
    Hoefer, Thomas
    Loehning, Max
    Thurley, Kevin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Gangliosides and the modulation of Th1/Th2 differentiation
    Crespo, FA
    Cripps, JG
    Fernandez-Botran, R
    FASEB JOURNAL, 2005, 19 (04): : A9 - A9
  • [50] Human CD4+ CD25+ CD127hi cells and the Th1/Th2 phenotype
    Narsale, Aditi
    Moya, Rosita
    Davies, Joanna Davida
    CLINICAL IMMUNOLOGY, 2018, 188 : 103 - 112